We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Role of Exposure in Hyperacusis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT04705246
Recruitment Status : Recruiting
First Posted : January 12, 2021
Last Update Posted : April 5, 2022
Universiteit Antwerpen
Information provided by (Responsible Party):
University Hospital, Antwerp

Brief Summary:
This study focuses on patients with a primary complaint of hyperacusis. Hyperacusis has been defined as 'abnormally reduced tolerance to sound'. It shows a high comorbidity with tinnitus, the perception of sound in the absence of a sound source. For the period of one month, hyperacusis and tinnitus severity and exposure to sounds will be evaluated by use of Ecological Momentary Assessment (EMA) in all participants. A novel approach to assessments, EMA prompts participants during their daily life to answer short questionnaires, increasing ecological validity and minimizing the risk for recall and memory biases. At a randomized time point during the one-month period, participants will individually receive a single psychoeducation session (1h) delivered by an experienced audiologist. The goal of the study is to investigate if the psychoeducation session leads to an increase in exposure to sound and a decrease in hyperacusis severity.

Condition or disease Intervention/treatment Phase
Hyperacusis Behavioral: Psychoeducation Not Applicable

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 5 participants
Allocation: N/A
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Effect of Psychoeducation Upon Exposure to Sounds and Hyperacusis Severity
Actual Study Start Date : December 7, 2020
Estimated Primary Completion Date : December 2022
Estimated Study Completion Date : December 2022

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Tinnitus

Arm Intervention/treatment
Experimental: Psychoeducation
The goal of the psychoeducation session is to provide insight in the hyperacusis symptoms, take away the fear of external noises, and encourage exposure to noise.
Behavioral: Psychoeducation
The goal of the psychoeducation session is to provide insight in the hyperacusis symptoms, take away the fear of external noises, and encourage exposure to noise.

Primary Outcome Measures :
  1. Change in EMA questions from baseline to end of the study [ Time Frame: 8 random time points each day during the period of the study, from baseline and after intervention, though study completion for an average of 1 month ]
    Change in questions concerning exposure, hyperacusis and tinnitus during the day from baseline measurement to last day of the study period

Secondary Outcome Measures :
  1. Hyperacusis Questionnaire [ Time Frame: before intervention, immediately post intervention ]
    Hyperacusis severity self-report questionnaire, ranging from 0-42 with a higher score representing a higher sensitivity to sounds. A score of 28 is the cut-off for auditory hypersensitivity.

  2. Tinnitus Functional Index (TFI) [ Time Frame: before intervention, immediately post intervention ]
    Tinnitus severity self-report questionnaire, ranging from 0-100 with a higher score representing a more severe tinnitus

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • primary complaint of hyperacusis

Exclusion Criteria:

  • primary complaint of misophonia
  • primary complaint of tinnitus
  • undergoing another therapy at the moment of the study

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04705246

Layout table for location contacts
Contact: Laure Jacquemin, PhD 038214233 laure_jacquemin@uza.be

Layout table for location information
University Hospital Antwerp Recruiting
Antwerp, Belgium
Contact: Laure Jacquemin, PhD         
Sponsors and Collaborators
University Hospital, Antwerp
Universiteit Antwerpen
Layout table for additonal information
Responsible Party: University Hospital, Antwerp
ClinicalTrials.gov Identifier: NCT04705246    
Other Study ID Numbers: Exposure in Hyperacusis
First Posted: January 12, 2021    Key Record Dates
Last Update Posted: April 5, 2022
Last Verified: April 2022
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: Undecided

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Hearing Disorders
Ear Diseases
Otorhinolaryngologic Diseases
Sensation Disorders
Neurologic Manifestations
Nervous System Diseases